TipRanks
Mereo Biopharma Group Plc (DE:MAH0)
FRANKFURT:MAH0
Germany Market
MAH0
Mereo Biopharma Group Plc
RESEARCH TOOLSreports

Mereo Biopharma Group Plc (MAH0) Income Statement

1 Followers

Mereo Biopharma Group Plc Income Statement

Last quarter (Q2 2026), Mereo Biopharma Group Plc's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q2, Mereo Biopharma Group Plc's net income was $-7.00M. See Mereo Biopharma Group Plc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 500.00K$ 0.00$ 10.00M$ 0.00$ 49.21M
Gross Profit
$ 367.00K$ 0.00$ 7.43M$ 1.15M$ 25.04M
Operating Expenses
$ 38.62M$ 0.00$ 35.84M$ 55.57M$ 53.30M
Depreciation and Amortization
$ 1.15M$ 1.09M$ 1.06M$ 889.00K$ 866.47K
EBITDA
$ -40.47M$ 1.09M$ -26.06M$ -37.87M$ 25.49M
Operating Income
$ -38.26M$ 0.00$ -28.42M$ -54.43M-
Other Income/Expenses
$ -3.62M$ 0.00$ -1.58M$ 11.49M$ 47.48M
Pretax Income
$ -41.88M$ 0.00$ -30.00M$ -42.94M$ 19.22M
Net Income
$ -41.88M$ 0.00$ -29.47M$ -42.22M$ 17.17M
Per Share Metrics
Basic EPS
$ -0.26$ 0.00$ -1.10K$ -1.80$ 749.65
Diluted EPS
$ -0.26$ 0.00$ -1.10K$ -1.80$ 749.65
Weighted Average Shares Outstanding
 159.42M 0.00 131.89M 22.80M 116.73M
Weighted Average Shares Outstanding (Diluted)
 159.42M 0.00 131.89M 22.80M 116.73M
Currency in USD

Mereo Biopharma Group Plc Earnings and Revenue History